Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

Trinquart L, Abbé A, Ravaud P.

PLoS One. 2012;7(4):e35219. doi: 10.1371/journal.pone.0035219. Epub 2012 Apr 20.

2.

Adjustment for reporting bias in network meta-analysis of antidepressant trials.

Trinquart L, Chatellier G, Ravaud P.

BMC Med Res Methodol. 2012 Sep 27;12:150. doi: 10.1186/1471-2288-12-150.

3.

Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.

Roest AM, de Jonge P, Williams CD, de Vries YA, Schoevers RA, Turner EH.

JAMA Psychiatry. 2015 May;72(5):500-10. doi: 10.1001/jamapsychiatry.2015.15.

PMID:
25806940
4.

Selective publication of antidepressant trials and its influence on apparent efficacy.

Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R.

N Engl J Med. 2008 Jan 17;358(3):252-60. doi: 10.1056/NEJMsa065779.

5.

Network meta-analysis of randomized clinical trials: reporting the proper summaries.

Zhang J, Carlin BP, Neaton JD, Soon GG, Nie L, Kane R, Virnig BA, Chu H.

Clin Trials. 2014 Apr;11(2):246-62. doi: 10.1177/1740774513498322. Epub 2013 Oct 3.

6.

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.

Hart B, Lundh A, Bero L.

BMJ. 2012 Jan 3;344:d7202. doi: 10.1136/bmj.d7202.

7.

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

Ioannidis JP.

Philos Ethics Humanit Med. 2008 May 27;3:14. doi: 10.1186/1747-5341-3-14.

8.

Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.

9.

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group..

CNS Drugs. 2008;22(7):587-602. Review.

PMID:
18547127
10.

Adjusting for publication biases across similar interventions performed well when compared with gold standard data.

Moreno SG, Sutton AJ, Ades AE, Cooper NJ, Abrams KR.

J Clin Epidemiol. 2011 Nov;64(11):1230-41. doi: 10.1016/j.jclinepi.2011.01.009. Epub 2011 May 6.

PMID:
21530169
11.

Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders.

Bereza BG, Machado M, Einarson TR.

Ann Pharmacother. 2008 Oct;42(10):1402-9. doi: 10.1345/aph.1L204. Epub 2008 Sep 2.

PMID:
18728102
12.

[Placebo effect in the drug therapy of depression].

Hougaard E, Nielsen T, Zachariae B.

Ugeskr Laeger. 2000 Apr 17;162(16):2314-7. Review. Danish.

PMID:
10827560
13.

Indirect comparisons of competing interventions.

Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ; International Stroke Trial Collaborative Group..

Health Technol Assess. 2005 Jul;9(26):1-134, iii-iv.

14.

Are antidepressants overrated? A review of methodological problems in antidepressant trials.

Moncrieff J.

J Nerv Ment Dis. 2001 May;189(5):288-95. Review.

PMID:
11379971
15.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
16.

Antidepressants and the placebo response.

Kirsch I.

Epidemiol Psichiatr Soc. 2009 Oct-Dec;18(4):318-22.

PMID:
20170046
17.

Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).

Nagler EV, Webster AC, Vanholder R, Zoccali C.

Nephrol Dial Transplant. 2012 Oct;27(10):3736-45. doi: 10.1093/ndt/gfs295. Epub 2012 Aug 1. Review.

PMID:
22859791
18.

A test for reporting bias in trial networks: simulation and case studies.

Trinquart L, Ioannidis JP, Chatellier G, Ravaud P.

BMC Med Res Methodol. 2014 Sep 27;14:112. doi: 10.1186/1471-2288-14-112.

19.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
20.

Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.

Zafari Z, Thorlund K, FitzGerald JM, Marra CA, Sadatsafavi M.

Pharmacoeconomics. 2014 Oct;32(10):995-1004. doi: 10.1007/s40273-014-0179-1.

PMID:
24920194

Supplemental Content

Support Center